A Randomized, Controlled, Double-Blind Study Comparing the Survival Benefit of Four Different Reverse Transcriptase Inhibitor Therapies (Three-Drug, Two-Drug, and Alternating Drug) for the Treatment of Advanced AIDS

Keith Henry, James O. Kahn, Camlin Tierney et al.|Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology|1998

Cited by 86